
    
      A multicenter, open label, uncontrolled study to evaluate the acceptability, tolerability,
      and nutritional suitability of a medical food (Renastart, Vitaflo International Ltd)
      specially formulated to meet the unique nutritional needs of children from birth to 10 years
      with chronic kidney disease (CKD)

      Primary Objective To investigate the nutritional suitability of Renastart in children aged 10
      years and under with CKD, particularly with respect to the dietary management of hyperkalemia
      and the maintenance / improvement of growth.

      Secondary Objectives To investigate the acceptance, compliance, palatability, and tolerance
      of Renastart in children aged under 10 years with CKD.

      A total of 15 children with CKD will be enrolled in the study.
    
  